MedPath

An ayurvedic intervension for gastro-esophageal reflux disease

Phase 1
Conditions
Health Condition 1: K21- Gastro-esophageal reflux disease
Registration Number
CTRI/2024/06/069659
Lead Sponsor
Dr JANANI D RAO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects having at least 3 of the classical symptoms of Amlapitta as described in Ayurvedic literature will be included Symptoms must be present for atleast 3 days in a week for about 3 months to be included in the study

Subjects who are willing to participate in the study

Exclusion Criteria

Previously diagnosed with or having any history of ulceration of stomach esophagus and duodenum and other systemic diseases such as hupertension cardiovascular ailmentsnephropathic and any type of malignant disorders

Subjects who have undergone recent surgeries

Subjects who are not fit for Vamana Dhauti

Pregnant lady and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
assesment of avipaka, klama, utklesha tikta amlaodgara gourava hrit kanta dahaa aruchi will be done to evatuate the effectiveness of vamana dhauti and Sarivadya Hima in AmlapittaTimepoint: at 15th day, 31st day and 46th day
Secondary Outcome Measures
NameTimeMethod
Assessment of avipaka, klama, utklesha, tikta-amlodgara, gourava, hrit kanta daha, aruchi will be done to compare the efffectiveness of Vamana Dhauti, Vamana Dhauti with Sarivadya Hima, & Sarivadya Hima alone in AmlapittaTimepoint: 15th day <br/ ><br>31st day <br/ ><br>46th day
Âİ Copyright 2025. All Rights Reserved by MedPath